Kaur R, Sharma A, Wijekoon N
EXCLI J. 2025; 24:267-285.
PMID: 40071025
PMC: 11895054.
DOI: 10.17179/excli2024-7973.
Asberger J, Ge I, Schmidt B, Jager M, Weiss D, Berner K
Exp Ther Med. 2025; 29(3):54.
PMID: 39885910
PMC: 11775725.
DOI: 10.3892/etm.2025.12804.
James C, Whitehead A, Plummer J, Thompson R, Badal S
Cancer Metastasis Rev. 2024; 43(4):1529-1548.
PMID: 39060878
DOI: 10.1007/s10555-024-10202-w.
Ferreira T, Faustino-Rocha A, Gaspar V, Medeiros R, Mano J, Oliveira P
Vet World. 2024; 17(5):1052-1072.
PMID: 38911075
PMC: 11188899.
DOI: 10.14202/vetworld.2024.1052-1072.
Rocha Tapia A, Abgottspon F, Nilvebrant J, Nygren P, Ivetich S, Bello Hernandez A
Chem Sci. 2024; 15(23):8982-8992.
PMID: 38873052
PMC: 11168188.
DOI: 10.1039/d4sc01838a.
Cell morphology best predicts tumorigenicity and metastasis in vivo across multiple TNBC cell lines of different metastatic potential.
Conner S, Guarin J, Le T, Fatherree J, Kelley C, Payne S
Breast Cancer Res. 2024; 26(1):43.
PMID: 38468326
PMC: 10929179.
DOI: 10.1186/s13058-024-01796-8.
Molecular, Cellular, and Technical Aspects of Breast Cancer Cell Lines as a Foundational Tool in Cancer Research.
Witt B, Tollefsbol T
Life (Basel). 2023; 13(12).
PMID: 38137912
PMC: 10744609.
DOI: 10.3390/life13122311.
Establishment of triple-negative breast cancer cells based on BMI: A novel model in the correlation between obesity and breast cancer.
Shveid Gerson D, Gerson-Cwilich R, Lara Torres C, Chousleb de Kalach A, Ventura Gallegos J, Badillo-Garcia L
Front Oncol. 2023; 12:988968.
PMID: 36591465
PMC: 9795201.
DOI: 10.3389/fonc.2022.988968.
Establishment and characterization of immortalized human breast cancer cell lines from breast cancer patient-derived xenografts (PDX).
Zhuang Y, Grainger J, Vedell P, Yu J, Moyer A, Gao H
NPJ Breast Cancer. 2021; 7(1):79.
PMID: 34145270
PMC: 8213738.
DOI: 10.1038/s41523-021-00285-x.
Gynaecological cancers and their cell lines.
Skok K, Gradisnik L, Maver U, Kozar N, Sobocan M, Takac I
J Cell Mol Med. 2021; 25(8):3680-3698.
PMID: 33650759
PMC: 8051715.
DOI: 10.1111/jcmm.16397.
Breast Cancer Reconstruction: Design Criteria for a Humanized Microphysiological System.
Frazier T, Williams C, Henderson M, Duplessis T, Rogers E, Wu X
Tissue Eng Part A. 2021; 27(7-8):479-488.
PMID: 33528293
PMC: 8196546.
DOI: 10.1089/ten.TEA.2020.0372.
New generation breast cancer cell lines developed from patient-derived xenografts.
Finlay-Schultz J, Jacobsen B, Riley D, Paul K, Turner S, Ferreira-Gonzalez A
Breast Cancer Res. 2020; 22(1):68.
PMID: 32576280
PMC: 7310532.
DOI: 10.1186/s13058-020-01300-y.
Differential Expression of Nicotine Acetylcholine Receptors Associates with Human Breast Cancer and Mediates Antitumor Activity of αO-Conotoxin GeXIVA.
Sun Z, Zhangsun M, Dong S, Liu Y, Qian J, Zhangsun D
Mar Drugs. 2020; 18(1).
PMID: 31963558
PMC: 7024346.
DOI: 10.3390/md18010061.
MicroRNAs as possible indicators of drug sensitivity in breast cancer cell lines.
Uhr K, Prager-van der Smissen W, Heine A, Ozturk B, van Jaarsveld M, Boersma A
PLoS One. 2019; 14(5):e0216400.
PMID: 31063487
PMC: 6504094.
DOI: 10.1371/journal.pone.0216400.
Isolation and characterization of a new naturally immortalized human breast carcinoma cell line, KAIMRC1.
Ali R, Samman N, Al Zahrani H, Nehdi A, Rahman S, Khan A
BMC Cancer. 2017; 17(1):803.
PMID: 29187162
PMC: 5707794.
DOI: 10.1186/s12885-017-3812-5.
Breast Cancer Cell Line Classification and Its Relevance with Breast Tumor Subtyping.
Dai X, Cheng H, Bai Z, Li J
J Cancer. 2017; 8(16):3131-3141.
PMID: 29158785
PMC: 5665029.
DOI: 10.7150/jca.18457.
Entry, Intracellular Survival, and Multinucleated-Giant-Cell-Forming Activity of Burkholderia pseudomallei in Human Primary Phagocytic and Nonphagocytic Cells.
Whiteley L, Meffert T, Haug M, Weidenmaier C, Hopf V, Bitschar K
Infect Immun. 2017; 85(10).
PMID: 28760929
PMC: 5607410.
DOI: 10.1128/IAI.00468-17.
Advances in the development of improved animal-free models for use in breast cancer biomedical research.
Roberts S, Speirs V
Biophys Rev. 2017; 9(4):321-327.
PMID: 28748520
PMC: 5578919.
DOI: 10.1007/s12551-017-0276-4.
Are your results valid? Cellular authentication a need from the past, an emergency on the present.
Cosme B, Falagan-Lotsch P, Ribeiro M, Napoleao K, Granjeiro J, Moura-Neto R
In Vitro Cell Dev Biol Anim. 2017; 53(5):430-434.
PMID: 28127703
DOI: 10.1007/s11626-016-0124-z.
Hypoxia-regulated gene expression explains differences between melanoma cell line-derived xenografts and patient-derived xenografts.
Bhadury J, Einarsdottir B, Podraza A, Olofsson Bagge R, Stierner U, Ny L
Oncotarget. 2016; 7(17):23801-11.
PMID: 27009863
PMC: 5029664.
DOI: 10.18632/oncotarget.8181.
